Arrowhead Research | ARWR - Ordinary Share Capital

Stock Price
76.67
Daily Change
-3.02 -3.79%
Monthly
12.78%
Yearly
388.03%
Q2 Forecast
75.13

Arrowhead Research reported $137.39M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
Alnylam Pharmaceuticals USD 133.44M 1.07M Mar/2026
Anika Therapeutics USD 13.89M 532K Dec/2025
Arrowhead Research USD 137.39M 1.69M Dec/2025
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Incyte USD 199.95M 1.49M Mar/2026
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
Ligand Pharmaceuticals USD 19.66M 19.64M Sep/2025
Merck USD 2.47B 12.72M Dec/2025
Moderna USD 391M 2M Sep/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Novartis USD 1.91B 60K Mar/2026
Sarepta Therapeutics USD 105.57M 607K Mar/2026
TG Therapeutics USD 155.31M 95K Dec/2025
Ultragenyx Pharmaceutical USD 98.3M 1.7M Mar/2026
Vertex Pharmaceuticals USD 254.2M 200K Mar/2026
Xencor USD 74.06M 2.19M Mar/2026